Alessandra Pescarollo

San Raffaele University of Rome — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index1.3kcitations23works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(7), Hematopoietic Stem Cell Transplantation(6), CAR-T cell therapy research(6), Lymphoma Diagnosis and Treatment(5), Acute Myeloid Leukemia Research(4)

Publications23 total

7129 Long-term follow-up of metastatic renal cancer patients undergoing HLA-identical reduced-intensity allografting
European Journal of Cancer Supplements·2009
Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma
Annals of Hematology·2009· 38 cited
Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting
Journal of Clinical Oncology·2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
The Lancet Oncology·2009· 481 cited
Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting
Bone Marrow Transplantation·2009· 17 cited
Long-Term Follow-Up of Metastatic Renal Cancer Patients Undergoing Reduced-Intensity Allografting
Biology of Blood and Marrow Transplantation·2009· 1 citedOpen Access
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality
Blood·2008
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
Leukemia·2007· 70 cited
Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation
Blood·2007· 171 citedOpen Access
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells
Proceedings of the National Academy of Sciences·2006· 186 citedOpen Access
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer
Bone Marrow Transplantation·2006· 2 cited
HSV-TK Engineered Donor Lymphocytes Add-Backs Reduce Late Mortality and Improve Survival of High Risk Acute Leukemia after Haplo-HSCT: Results of a Phase II Multicenter Trial.
Blood·2005· 2 cited
High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).
Blood·2005· 1 cited
A Phase II Multicenter Trial of HSV-TK Engineered Donor Lymphocytes after Haplo-Identical HSCT: Early Immune Reconstitution and Abrogation of Gvhd.
Blood·2004· 2 cited
Rituximab-Supplemented High-Dose Sequential (HDS) Chemotherapy with Autograft Is Highly Effective in High-Risk (aaIPI 2–3) Diffuse Large B-Cell Lymphoma: Results of a Prospective Multicenter Study on 91 Consecutive Patients Treated at Diagnosis.
Blood·2004· 3 cited
Molecular Follow-Up of Patients Treated with HSV-TK/ΔLNGFR Engineered Donor Lymphocytes after Allogeneic Stem Cell Transplantation.
Blood·2004
High‐dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma
Cancer·2003· 72 citedOpen Access
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer
Blood·2002· 207 citedOpen Access
Thalidomide and thrombosis in patients with multiple myeloma.
PubMed·2001· 28 cited
Complete haematological response with granulocyte colony stimulating factor (G-CSF) and hydroxyurea in relapsed acute myeloid leukaemia (AML) of the elderly.
PubMed·2001· 2 cited
page 1 of 2Next →

Frequent Co-authors

Marco Bregni(18), Fabio Ciceri(13), Massimo Bernardi(12), Jacopo Peccatori(12), Paolo Corradini(11), Claudio Bordignon(9), Paolo Servida(8), Chiara Bonini(7), Zulma Magnani(7), Roberto Crocchiolo(7), Attilio Bondanza(6), Maria Teresa Lupo Stanghellini(5), Monica Salomoni(5), Luciano Callegaro(5), Maurilio Ponzoni(5), Corrado Tarella(5), Alessandro M. Gianni(5), Scialini Colombi(4), Serena Perna(4), Fulvio Crippa(4)